Damien Amelin

Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies

K. Mariampillai, Benjamin Granger, Damien Amelin et al. · JAMA Neurology · 2018 · 422 citations · Full text

JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis

Leandro Ladislau, Xavier Suárez‐Calvet, S. Toquet et al. · Brain · 2018 · 231 citations · Full text

Muscle Tissue, Induced Damage, Immunology +17

Necrosis in anti-SRP ⁺ and anti-HMGCR ⁺ myopathies

Yves Allenbach, Louiza Arouche-Delaperche, Helena Radbruch et al. · Neurology · 2018 · 178 citations

Pathogenic role of anti–signal recognition protein and anti–3‐Hydroxy‐3‐methylglutaryl‐<scp>C</scp>o<scp>A</scp> reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies

Louiza Arouche-Delaperche, Yves Allenbach, Damien Amelin et al. · Annals of Neurology · 2017 · 158 citations

Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial

Olivier Benvéniste, Jean‐Yves Hogrel, Lisa Belin et al. · The Lancet Rheumatology · 2020 · 70 citations · Full text

Medicine, Surgery, Inclusion Body Myositis